DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,994 | +2.4% | 36,251 | -0.9% | 0.21% | +0.5% |
| Q2 2023 | $8,781 | -44.6% | 36,586 | -41.9% | 0.21% | -50.6% |
| Q1 2023 | $15,858 | -28.4% | 62,918 | -24.6% | 0.42% | -28.6% |
| Q4 2022 | $22,134 | -99.9% | 83,392 | +40.4% | 0.59% | -24.5% |
| Q3 2022 | $15,339,000 | +54.7% | 59,386 | +51.8% | 0.78% | +84.6% |
| Q2 2022 | $9,916,000 | +346.1% | 39,113 | +416.1% | 0.42% | +397.6% |
| Q1 2022 | $2,223,000 | +2.4% | 7,579 | +14.9% | 0.08% | +6.2% |
| Q4 2021 | $2,170,000 | -76.7% | 6,597 | -78.5% | 0.08% | -77.3% |
| Q3 2021 | $9,332,000 | -6.2% | 30,653 | -17.3% | 0.35% | -7.6% |
| Q2 2021 | $9,945,000 | +99.5% | 37,058 | +67.4% | 0.38% | +88.2% |
| Q1 2021 | $4,984,000 | +257.3% | 22,144 | +252.7% | 0.20% | +232.8% |
| Q4 2020 | $1,395,000 | -48.3% | 6,278 | -49.9% | 0.06% | -50.4% |
| Q3 2020 | $2,696,000 | +88.5% | 12,520 | +54.8% | 0.12% | +68.5% |
| Q2 2020 | $1,430,000 | -50.4% | 8,088 | -57.0% | 0.07% | -46.3% |
| Q4 2019 | $2,884,000 | -70.1% | 18,793 | -71.9% | 0.14% | -71.3% |
| Q3 2019 | $9,648,000 | -48.2% | 66,799 | -48.7% | 0.47% | -46.4% |
| Q2 2019 | $18,611,000 | +14.8% | 130,220 | +6.0% | 0.88% | +8.5% |
| Q1 2019 | $16,216,000 | -14.3% | 122,832 | -33.0% | 0.82% | -32.5% |
| Q4 2018 | $18,912,000 | -17.4% | 183,395 | -13.0% | 1.21% | -15.4% |
| Q3 2018 | $22,908,000 | +1.9% | 210,825 | -7.5% | 1.43% | -11.1% |
| Q2 2018 | $22,484,000 | -24.7% | 227,850 | -25.3% | 1.61% | -30.3% |
| Q1 2018 | $29,858,000 | +59.0% | 304,950 | +50.8% | 2.31% | +64.0% |
| Q4 2017 | $18,773,000 | +9.6% | 202,250 | +1.3% | 1.41% | +9.1% |
| Q3 2017 | $17,135,000 | +11.8% | 199,750 | +10.0% | 1.29% | +12.5% |
| Q2 2017 | $15,329,000 | -47.1% | 181,650 | -46.4% | 1.15% | -45.2% |
| Q1 2017 | $28,990,000 | +9.7% | 338,950 | -0.1% | 2.09% | +0.6% |
| Q4 2016 | $26,423,000 | -16.9% | 339,450 | -16.3% | 2.08% | -22.4% |
| Q3 2016 | $31,783,000 | -25.8% | 405,450 | -4.3% | 2.68% | -32.3% |
| Q2 2016 | $42,809,000 | -5.5% | 423,850 | -11.3% | 3.96% | +16.0% |
| Q1 2016 | $45,310,000 | +3.1% | 477,650 | +0.9% | 3.41% | -2.2% |
| Q4 2015 | $43,965,000 | +9.6% | 473,350 | +0.6% | 3.49% | -7.5% |
| Q3 2015 | $40,113,000 | +0.7% | 470,750 | +1.2% | 3.77% | +6.7% |
| Q2 2015 | $39,829,000 | +0.6% | 465,350 | -0.2% | 3.54% | -8.6% |
| Q1 2015 | $39,602,000 | +37.0% | 466,450 | +38.3% | 3.87% | +20.9% |
| Q4 2014 | $28,906,000 | +20.1% | 337,250 | +6.4% | 3.20% | +9.9% |
| Q3 2014 | $24,074,000 | -39.2% | 316,850 | -37.0% | 2.91% | -32.5% |
| Q2 2014 | $39,621,000 | +26.5% | 503,250 | +20.5% | 4.31% | +13.8% |
| Q1 2014 | $31,324,000 | – | 417,650 | – | 3.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |